Search

everythinglearnresearchcommunity

for

Search:↓

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

IL-17 and certain immune cells are linked to more severe alopecia areata.

The study suggests that hypothyroidism may cause alopecia areata.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

Baby teeth stem cells can potentially grow organs and treat diseases.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Acne is a temporary skin imbalance during puberty that often resolves on its own.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

New insights into cell communication in psoriasis suggest innovative drug treatments.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.